Frontlight ResearchEarly access
Trial site
Freiburg im Breisgau
- 18running trials
- 5closed trials
The trials here
What the 23 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Multiple myeloma4 trials
- Metastatic breast cancer3 trials
- Dermatomyositis and polymyositis (myositis)2 trials
- Asthma1 trial
- COPD1 trial
- Head and neck cancer1 trial
- Heart failure1 trial
- Idiopathic pulmonary fibrosis1 trial
- Lupus (SLE)1 trial
- Mesothelioma1 trial
- Obesity1 trial
- and 3 more
- Phase
- Phase 316 trials
- Phase 23 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Active, not recruiting7 trials
- Not yet recruiting7 trials
- Recruiting4 trials
- Completed3 trials
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- AstraZeneca21 trials
- Alexion Pharmaceuticals, Inc.1 trial
- MedImmune LLC1 trial
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Recruiting
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple myeloma3 recruiting
- Dermatomyositis and polymyositis (myositis)1 recruiting
- Head and neck cancer1 recruiting
- Heart failure1 recruiting
- Idiopathic pulmonary fibrosis1 recruiting
- Lupus (SLE)1 recruiting
- Metastatic breast cancer1 recruiting
- Obesity1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 13 Nov 2026